Literature DB >> 11481408

Inflammatory responses to lipopolysaccharide are suppressed in 40% energy-restricted mice.

J Matsuzaki1, M Kuwamura, R Yamaji, H Inui, Y Nakano.   

Abstract

To elucidate the suppressive effects of energy restriction on the inflammatory responses to lipopolysaccharide (LPS), mice were divided into a control group (fed 5.0 g diet/d; 71 kJ/d) and a 40% energy-restricted group (fed 3.0 g diet/d; 43 kJ/d) at 8-wk of age. Four weeks later, 25 microg of LPS was intraperitoneally injected. After the LPS injection, interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha were elevated in serums in the 40% energy-restricted mice and in the controls, but the extent of the elevation was significantly lower in the restricted group. The LPS-induced expression of inducible nitric oxide synthase in the liver was significantly suppressed by the energy restriction. In addition, the LPS-induced elevations of serum aspartate and alanine aminotransferase activities, which are indexes of hepatic injury, were also significantly attenuated in the restricted group. Moreover, the extent of LPS-induced alterations in hepatic structure was less in the restricted mice than in controls. Serum corticosterone level in the restricted mice was higher than that in the controls before LPS treatment (P < 0.05). Furthermore, after LPS injection, the significantly higher level of corticosterone was maintained in the restricted mice, although the LPS treatment significantly enhanced the level even in the control group. These results suggest that the extreme inflammatory responses to endotoxin are prevented in the 40% energy-restricted mice, and corticosterone participates in the preventive effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481408     DOI: 10.1093/jn/131.8.2139

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  30 in total

Review 1.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

Review 2.  Age-related cardiovascular disease and the beneficial effects of calorie restriction.

Authors:  Miranda M Y Sung; Jason R B Dyck
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 3.  Diet, behavior and immunity across the lifespan.

Authors:  Matthew W Hale; Sarah J Spencer; Bruno Conti; Christine L Jasoni; Stephen Kent; Morgan E Radler; Teresa M Reyes; Luba Sominsky
Journal:  Neurosci Biobehav Rev       Date:  2014-12-15       Impact factor: 8.989

Review 4.  Brain response to calorie restriction.

Authors:  Salvatore Fusco; Giovambattista Pani
Journal:  Cell Mol Life Sci       Date:  2012-12-27       Impact factor: 9.261

5.  Body mass affects seasonal variation in sickness intensity in a seasonally breeding rodent.

Authors:  Elizabeth D Carlton; Gregory E Demas
Journal:  J Exp Biol       Date:  2015-04-07       Impact factor: 3.312

6.  A meta-analysis of the effects of energy intake on risk of digestive cancers.

Authors:  Xiao-Feng Yu; Yi-Qian Wang; Jian Zou; Jie Dong
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis.

Authors:  Laura Piccio; Jennifer L Stark; Anne H Cross
Journal:  J Leukoc Biol       Date:  2008-08-04       Impact factor: 4.962

8.  Annual fasting; the early calories restriction for cancer prevention.

Authors:  Solat Eslami; Zahra Barzgari; Negar Saliani; Nazli Saeedi; Abolfazl Barzegari
Journal:  Bioimpacts       Date:  2012-12-21

Review 9.  Calorie restriction and cancer prevention: metabolic and molecular mechanisms.

Authors:  Valter D Longo; Luigi Fontana
Journal:  Trends Pharmacol Sci       Date:  2010-01-25       Impact factor: 14.819

10.  Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines.

Authors:  D Eads; Rl Hansen; Ao Oyegunwa; Ce Cecil; Ca Culver; F Scholle; Itd Petty; Sm Laster
Journal:  J Inflamm (Lond)       Date:  2009-01-08       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.